Shaker Investments’s Moderna MRNA Stock Holding History

Shaker Investments’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,314	Closed	-$524K	–	89
2023 Q2	$524K	Sell	4,314 -4,710	-52%	-$628K	0.27%	77
2023 Q1	$1.39M	Buy	+9,024	New	+$1.49M	0.77%	46

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Shaker Investments's MRNA Position: Q3 2023 in Review

Shaker Investments sold out of Moderna (MRNA) in Q3 2023, closing a stake of 4,314 shares — an estimated $524K sold.

Shaker Investments first reported a position in MRNA in Q1 2023 and held it in 2 quarters. The position peaked at $1.39M in Q1 2023. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

Shaker Investments reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
Shaker Investments sold 4,314 Moderna shares in Q3 2023, an estimated $524K.
Shaker Investments first reported a position in Moderna in Q1 2023 and held it in 2 quarters.
Shaker Investments's Moderna position peaked at $1.39M in Q1 2023.
890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Shaker Investments's 13F filing for Q3 2023, filed 24 Oct 2023.